Boehringer Ingelheim reinforces its beef and dairy livestock portfolio in Brazil

Boehringer Ingelheim is helping cattle farmers combat bovine’s farming greatest enemies.

The product releases made in the first half of 2018 reinforce one of the main pillars of the company: innovation. Boehringer Ingelheim invests approximately 9 per cent of animal health revenue into R&D, focusing on solutions to prevent diseases that directly affect the productivity of production animals.

Boehringer Ingelheim Animal Health business recently attended Expointer, an agricultural show considered the largest livestock event in Latin America. It takes place annually in the Parque de Exposições Assis Brasil in the city of Esteio, in the metropolitan area of Porto Alegre in the Brazilian state of Rio Grande do Sul.

The event welcomes farmers from all over Latin America. “Expointer is an excellent moment to showcase our full portfolio. The farmers go to the fair interested in learning about the solutions to control and prevent sanitary problems in their herds. Every year we enhance our space at Expointer to receive our customers in the best environment, since it’s a great opportunity to present our work, reinforcing the partnership and priority to attend to the needs of farmers," highlights Fabio Barone, Head of Boehringer Ingelheim Animal Health in Brazil.

According to Fabio Barone, with Bovela™ against BVD, the parasiticide Neox™ Pour On and the IATF (Artificial Insemination in Fixed Time) Control package, highlighted at the event as products released in 2018, the company reinforces its commitment to innovation aimed at livestock, helping farmers get better economic results in their business. “We create value through innovation for our clients. We understand the challenges and continue to grow our portfolio to improve animal health, always focusing on prevention, animal well-being and the subsequent increase in productivity,” explains Fabio Barone.

“These products arrive at the market to assist cattle farmers in important areas which impact their productivity. Offering innovative and highly effective solutions is our priority,” concludes Nivaldo Grando Jr, new director of the Boehringer Ingelheim’s Animal Health Ruminants division.